Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Opiate Reduction After Pulmonary Resection
NCT05100160Phase 3Withdrawn
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gabapentin in postoperative pain, sponsored by University of Texas MD Anderson Cancer Center. Planned start Sep 2021; status: withdrawn.
02
Drugs
gabapentin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05100160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05100160.